FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Farmakeio Outsourcing Testosterone / Triamcinolone Acetonide Pellet Recall

Testosterone / Triamcinolone Acetonide Pellet (100MG/20MCG), 1 PELLET (STERILE) FOR SUB…

FARMAKEIO OUTSOURCING LLC · Southlake, TX

Risk level
Class II
Reported by FDA
Nov 5, 2025
Recall ID
D-0136-2026
Check your lot numberHow we source this data

Summary

Farmakeio Outsourcing recalled Testosterone / Triamcinolone Acetonide Pellet starting Oct 14, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0136-2026 on Nov 5, 2025. Reason: CGMP Deviations: Potential presence of metal particulate matter. Status: Ongoing.

Why it was recalled

CGMP Deviations: Potential presence of metal particulate matter

Product description

Testosterone / Triamcinolone Acetonide Pellet (100MG/20MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0367-01

Lot numbers, UPCs & expiration codes

Lot, expiry: 3098, 3101, Exp 1/8/2026; 3107, Exp 1/13/2026; 3108, Exp 1/14/2026; 3109, Exp 1/15/2026; 3230, Exp 3/10/2026; 3231, Exp 3/11/2026; 3235, Exp 3/13/2026; 3236, Exp 3/17/2026; 3241, Exp 3/17/2026; 3242, Exp 3/18/2026.

Where it was sold

Nationwide in the USA and Antigua

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0136-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 14, 2025
FDA report date
Nov 5, 2025
Quantity
103,444 pellets
Recall type
Voluntary: Firm initiated
Recalling firm
FARMAKEIO OUTSOURCING LLC

Original FDA data

Every field from FDA enforcement report D-0136-2026, exactly as published.

Show all FDA fields
City
Southlake
State
TX
Status
Ongoing
Country
United States
Event ID
97799
Address
920 S Kimball Ave Ste 100
Code information
Lot, expiry: 3098, 3101, Exp 1/8/2026; 3107, Exp 1/13/2026; 3108, Exp 1/14/2026; 3109, Exp 1/15/2026; 3230, Exp 3/10/2026; 3231, Exp 3/11/2026; 3235, Exp 3/13/2026; 3236, Exp 3/17/2026; 3241, Exp 3/17/2026; 3242, Exp 3/18/2026.
Postal code
76092-9019
Report date
Nov 5, 2025
Product type
Drugs
Recall number
D-0136-2026
Classification
Class II
Recalling firm
FARMAKEIO OUTSOURCING LLC
Product quantity
103,444 pellets
Reason for recall
CGMP Deviations: Potential presence of metal particulate matter
Voluntary / mandated
Voluntary: Firm initiated
Product description
Testosterone / Triamcinolone Acetonide Pellet (100MG/20MCG), 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0367-01
Distribution pattern
Nationwide in the USA and Antigua
Recall initiation date
Oct 14, 2025
Initial firm notification
E-Mail
Center classification date
Oct 29, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0136-2026, published Nov 5, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls